Literature DB >> 10396127

The 5-HT1A receptor and its ligands: structure and function.

B Olivier1, W Soudijn, I van Wijngaarden.   

Abstract

An overview is presented on progress made in research on 5-HT1A receptors and their ligands since their discovery in 1983. Molecular biology has offered new tools, for example cloned 5-HT1A receptors, their mutants and chimeras to study structure and function. Many compounds, belonging to different chemical classes, display high affinity and selectivity for 5-HT1A receptors. The majority of these compounds are agonists or partial agonists, full antagonists are still scarce. Agonists and partial agonists are active in various animal models of anxiety and depression. Partial receptor agonists have been proven to be effective in general anxiety disorder and depression in man. Potential therapeutic applications for 5-HT1A receptor antagonists are evaluated, for example, in cognition disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10396127     DOI: 10.1007/978-3-0348-8730-4_3

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN: 0071-786X


  15 in total

1.  Characterization of the functional heterologous desensitization of hypothalamic 5-HT(1A) receptors after 5-HT(2A) receptor activation.

Authors:  Y Zhang; D D'Souza; D K Raap; F Garcia; G Battaglia; N A Muma; L D Van de Kar
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

Review 2.  Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications.

Authors:  Zhen Yan
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.590

3.  Classification of 5-HT(1A) receptor agonists and antagonists using GA-SVM method.

Authors:  Xue-lian Zhu; Hai-yan Cai; Zhi-jian Xu; Yong Wang; He-yao Wang; Ao Zhang; Wei-liang Zhu
Journal:  Acta Pharmacol Sin       Date:  2011-10-03       Impact factor: 6.150

4.  5-HT1A receptor pharmacophores to screen for off-target activity of α1-adrenoceptor antagonists.

Authors:  Tony Ngo; Timothy J Nicholas; Junli Chen; Angela M Finch; Renate Griffith
Journal:  J Comput Aided Mol Des       Date:  2013-04-27       Impact factor: 3.686

5.  Activation of postsynaptic 5-HT1A receptors improve stress adaptation.

Authors:  Jiansong Zhou; Xia Cao; Adam C Mar; Yu-Qiang Ding; Xiaoping Wang; Qi Li; Lingjiang Li
Journal:  Psychopharmacology (Berl)       Date:  2013-11-21       Impact factor: 4.530

Review 6.  Trends in the development of new antidepressants. Is there a light at the end of the tunnel?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Med Chem       Date:  2004-04       Impact factor: 4.530

7.  Synthesis of a new scaffold: the 7H,8H-pyrimido[1,6-b]pyridazin-6,8-dione nucleus.

Authors:  Franciszek Herold; Małgorzata Kałucka; Marek Król; Joanna Herold; Jerzy Kleps; Jadwiga Turło
Journal:  Molecules       Date:  2007-12-30       Impact factor: 4.411

8.  Stress-induced susceptibility to sudden cardiac death in mice with altered serotonin homeostasis.

Authors:  Luca Carnevali; Francesca Mastorci; Enrica Audero; Gallia Graiani; Stefano Rossi; Emilio Macchi; Sergio Callegari; Alessandro Bartolomucci; Eugene Nalivaiko; Federico Quaini; Cornelius Gross; Andrea Sgoifo
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

9.  The C(-1019)G 5-HT1A promoter polymorphism and personality traits: no evidence for significant association in alcoholic patients.

Authors:  G Koller; B Bondy; U W Preuss; P Zill; M Soyka
Journal:  Behav Brain Funct       Date:  2006-02-25       Impact factor: 3.759

10.  The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders.

Authors:  Jocelien D A Olivier; Christiaan H Vinkers; Berend Olivier
Journal:  Front Pharmacol       Date:  2013-06-11       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.